Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novacyt (FR:ALNOV)
PARIS:ALNOV
Holding FR:ALNOV?
Track your performance easily
ALNOV Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.49 - €1.59
Previous Close€0.63
Volume149.12K
Average Volume (3M)1.20M
Market Cap
€44.92M
Enterprise Value-€57.86M
Total Cash (Recent Filing)£87.17M
Total Debt (Recent Filing)£872.00K
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding70,626,248
10 Day Avg. Volume414,096
30 Day Avg. Volume1,199,016
Standard Deviation0.55
R-Squared0.07
Alpha0.14
Financial Highlights & Ratios
Price to Book (P/B)0.34
Price to Sales (P/S)935.93
Price to Cash Flow (P/CF)-289.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Novacyt News
PremiumCompany Announcements
Novacyt Updates on Liquidity and Market Position
PremiumCompany Announcements
Novacyt Appoints Expert to Strengthen BoardPremiumCompany Announcements
Novacyt Gains EU Accreditation for Cystic Fibrosis TestPremiumCompany Announcements
Novacyt S.A. Shuts Down IT-IS SubsidiaryPremiumCompany Announcements
Novacyt S.A. Reports Monthly Share Trades
PremiumCompany Announcements
Novacyt Reports Strong Growth and Profit in H1 2024
PremiumCompany Announcements
Novacyt Appoints Industry Veteran as New Chairman
PremiumCompany Announcements
Novacyt Confirms Compliance Post-Yourgene TakeoverALNOV FAQ
What was Novacyt’s price range in the past 12 months?
Novacyt lowest stock price was €0.49 and its highest was €1.59 in the past 12 months.
What is Novacyt’s market cap?
Currently, no data Available
When is Novacyt’s upcoming earnings report date?
Novacyt’s upcoming earnings report date is Apr 24, 2025 which is in 165 days.
How were Novacyt’s earnings last quarter?
Novacyt released its earnings results on Sep 26, 2024. The company reported -€0.293 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.293.
Is Novacyt overvalued?
According to Wall Street analysts Novacyt’s price is currently Overvalued.
Does Novacyt pay dividends?
Novacyt does not currently pay dividends.
What is Novacyt’s EPS estimate?
Novacyt’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novacyt have?
Novacyt has 70,626,250 shares outstanding.
What happened to Novacyt’s price movement after its last earnings report?
Novacyt reported an EPS of -€0.293 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.639%.
Which hedge fund is a major shareholder of Novacyt?
Currently, no hedge funds are holding shares in FR:ALNOV
---
Novacyt Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.22%
12-Months-Change
Fundamentals
Return on Equity
-41.72%
Trailing 12-Months
Asset Growth
-25.21%
Trailing 12-Months
Company Description
Novacyt
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through two business segments: Corporate and Diagnostics and Molecular Products.The Corporate and Diagnostics segment corresponds to diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kitsfor bacterial and blood tests. The Molecular Products segment represents the activities of Primerdesign, which designs, manufactures and distributes test kits for certaindiseases in humans, animals and food products.
---
ALNOV Company Deck
---
ALNOV Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
Achieve Life Sciences
―
Aethlon Medical
―
Aytu BioScience
―
BioNano Genomics
―
Novacyt
―
---